Target intelligence / Profile preview

miR-34a-regulated messenger RNAs

Molecular classification
Other (heterogeneous set of messenger RNAs)
01

Overview

miR-34a target mRNAs are the transcripts whose expression is suppressed by microRNA-34a, a master tumor suppressor and regulator of cell fate. miR-34a binds a complementary sequence in the 3'-UTR of hundreds of mRNAs—including proto-oncogenes (e.g., MYC, MET, CDK4/6, BCL2, SIRT1), differentiation factors, and senescence regulators—causing their degradation or silencing[1][2][3][5][7]. The tumor suppressive effect of miR-34a is largely due to its ability to simultaneously downregulate multiple genes involved in cell proliferation, apoptosis resistance, invasion, metastasis, stemness, and immune escape, making it a focus of diagnostic and therapeutic research in cancer and fibrosis[1][2][5][8]. Therapeutic strategies often aim at modulating miR-34a itself; the diverse downstream mRNA targets represent the molecular endpoints affected by such intervention, rather than actionable drug targets themselves. A canonical target for therapeutic intervention would be miR-34a (microRNA-34a), not "miR-34a target mRNAs"[1][2][5]. The listed mRNAs are highly context-dependent, and the set may vary based on species, cell type, and disease context[7][8].

Other names
miR-34a-regulated mRNAsmiR-34a target genesmiR-34a direct targets
02

Mechanism of action

Post-transcriptional silencing by miR-34a binding to mRNA 3'-UTR, resulting in mRNA degradation or translational repression

03

Biological functions

Cell cycle regulationApoptosisCell proliferationDifferentiationEMT (epithelial-mesenchymal transition)StemnessTumorigenesisImmune evasion
04

Disease associations

Cancer (tumor suppression and progression)FibrosisCardiovascular diseaseNeurological disease
05

Safety considerations

Broad targeting of multiple mRNAs risks off-target effects and adverse responses if therapeutically modulatedPotential interference with normal cell cycle and apoptosis in non-malignant cells
06

Biomarkers

Individual target mRNAs may serve as biomarkers (e.g., BCL2, SIRT1, MET, CDK4, CDK6, NOTCH1)miR-34a expression itself is widely used as a biomarker for cancer progression, treatment response, and prognosis

Beyond the preview

Go deeper on miR-34a-regulated messenger RNAs.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on miR-34a-regulated messenger RNAs.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call